Arix Bioscience — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Amplyxamplyx.comMay 2020

Developing a new class of antifungal medicine to overcome limitations of current therapies.

Co-investorsBioBrit Golden Seeds Keiretsu Forum Pappas Capital Sofinnova Ventures 3x5 Partners +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.